Welcome to our dedicated page for Milestone Scient news (Ticker: MLSS), a resource for investors and traders seeking the latest updates and insights on Milestone Scient stock.
Milestone Scientific Inc. (MLSS) is described in its public disclosures as a technology-focused medical research and development company that patents, designs and develops computerized injection technologies and instruments for medical, dental and cosmetic applications. The company’s news flow centers on its computerized drug delivery instruments, which are designed to provide painless and precise injections using its DPS Dynamic Pressure Sensing Technology® platform.
News updates commonly cover developments in Milestone Scientific’s dental segment, including expansion of direct sales programs in North America, new international registrations for the STA® Single Tooth Anesthesia System, and initiatives such as The Wand® Ambassador Program. That program uses experienced dental professionals to share real-world clinical insights and workflow considerations to support broader adoption of The Wand STA System.
In the medical segment, news items highlight the CompuFlo® technology and the CompuFlo Epidural System, including growing utilization of CompuFlo disposables, interest from hospitals and international distributors, and progress on reimbursement strategies. Milestone Scientific reports milestones such as Medicare Part B payment-rate assignments under CPT® code 0777T in several jurisdictions and early activity from commercial insurers, which it views as important for adoption in interventional pain management and spine intervention markets.
Other recurring themes in Milestone Scientific’s news include quarterly financial results, cost-management and operational transformation efforts, leadership appointments, board changes, and updates on NYSE American listing compliance matters. Investors and observers can use this news stream to follow the company’s commercial initiatives in dental and medical markets, its reimbursement and payer-access efforts, and its corporate and governance developments over time.
Milestone Scientific Inc. (NYSE American:MLSS) announced an investor webinar on September 14, 2020, at 4:00 p.m. ET, led by Interim CEO Leonard Osser. The session aims to discuss recent company developments and future milestones, followed by a live Q&A. Milestone is known for its innovative computerized drug delivery instruments, focusing on painless injections using its proprietary DPS Dynamic Pressure Sensing technology. Participants can register for the webinar online and pre-submit questions. The company emphasizes the forward-looking nature of its statements, which carry inherent risks and uncertainties.
Milestone Scientific (MLSS) anticipates a substantial increase in Q3 2020 dental revenues, projecting at least a four-fold rise compared to Q2 2020. The company's Wand® dental business is beginning to recover as dental offices reopen, aided by promotions to boost sales of disposables and instruments. Additionally, there is growth in active trials of the CompuFlo® Epidural System, with new partnerships and a strategy to shorten the sales cycle by lending instruments to hospitals. Overall, there is a robust sales pipeline and positive feedback from both domestic and international markets.
Milestone Scientific (MLSS) has announced the promotion of Jan Adriaan Haverhals to President, effective immediately. Haverhals, who joined the company in June 2020 as President and CEO of Wand Dental, brings over 30 years of experience in sales and marketing within the medical device sector. His leadership is expected to accelerate the commercialization of Milestone's CompuFlo® Epidural Instrument and CathCheck™ technologies in the U.S. and Europe. Leonard Osser, Interim CEO, expressed confidence in Haverhals' abilities to enhance sales and marketing efforts and foster collaborations with major health systems.
Milestone Scientific (NYSE American: MLSS) announced its participation in the LD 500 virtual investor conference from September 1-4, 2020. Interim CEO Len Osser will present on September 1 at 2:40 p.m. ET. The presentation will be available via a live webcast on the conference platform. One-on-one meetings can be requested online or via email. The LD 500 event will showcase key players in the small and micro-cap sector, featuring interviews and keynote speeches. For more details on Milestone Scientific's technology and services, visit their website.
Milestone Scientific (NYSE:MLSS) reported Q2 2020 revenues of approximately $167,000, down from $2.2 million in Q2 2019, significantly impacted by the COVID-19 pandemic. The operating loss for the quarter increased to approximately $(3.1) million, compared to $(1.1) million in the prior year. For the first six months, revenues dropped to $1.9 million from $4.1 million in H1 2019. Despite the downturn, the company ended the quarter with over $16.6 million in cash, allowing it to enhance sales activities and adapt to market conditions. The focus remains on the commercialization of the CompuFlo Epidural System.
Milestone Scientific Inc. (MLSS) announced a conference call on August 17, 2020, at 8:30 AM ET, to discuss its financial results for Q2 2020 ending June 30. The call aims to cover corporate progress and developments. Investors can participate via the company's website or by telephone. A replay will be available within an hour after the call until August 31, 2020. Milestone Scientific focuses on innovative drug delivery instruments that enhance injection precision and comfort, utilizing its proprietary Dynamic Pressure Sensing technology.
Milestone Scientific (NYSE American: MLSS) has announced a conference call scheduled for August 17, 2020, at 8:30 AM ET to discuss its financial results for Q2 2020 and corporate developments. Interested parties can access the call via the company's website or by dialing the appropriate toll-free numbers. The call will also be archived for later access. Milestone specializes in innovative injection technologies aimed at providing painless and precise injections, utilizing their proprietary DPS Dynamic Pressure Sensing technology.